Skip to main content
Advertisement
Advertisement
EOLS
EOLS logo
Evolus, Inc. Common Stock
7.00
USD
Sponsored
-0.07
-0.99%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

6.99

-0.01
-0.14%

Evolus, Inc. Common Stock (EOLS) Earnings

EOLS Earnings Reports

Positive Surprise Ratio

EOLS beat 23 of 36 last estimates.

64%

Next Report

Date of Next Report
Mar 01, 2027
Estimate for Q4 26 (Revenue/ EPS)
$101.12M
/
$0.06
Implied change from Q3 26 (Revenue/ EPS)
+29.72%
/
-250.00%
Implied change from Q4 25 (Revenue/ EPS)
+13.34%
/
+20.00%

Evolus, Inc. Common Stock earnings per share and revenue

On Nov 04, 2026, EOLS reported earnings of -0.04 USD per share (EPS) for Q3 26, beating the estimate of -0.06 USD, resulting in a 36.71% surprise. Revenue reached 77.95 million, compared to an expected 79.22 million, with a -1.60% difference. The market reacted with a -9.04% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.06 USD, with revenue projected to reach 101.12 million USD, implying an decrease of -250.00% EPS, and increase of 29.72% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q3 2026, Evolus, Inc. Common Stock reported EPS of -$0.04, beating estimates by 36.71%, and revenue of $77.95M, -1.6% below expectations.
The stock price moved down -9.04%, changed from $7.47 before the earnings release to $6.79 the day after.
The next earning report is scheduled for Mar 01, 2027.
Based on -- analysts, Evolus, Inc. Common Stock is expected to report EPS of $0.06 and revenue of $101.12M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement